Key Findings
The India sepsis diagnostics market is anticipated to grow with a CAGR of 8.80%, during the forecast period. The increased prevalence of sepsis, the surging number of fatalities associated with it, the absence of specific treatments, and reduced awareness of the medical condition in rural areas, are projected to fuel the country’s market growth. The base year considered for the studied market is 2020, and the forecast period is from 2021 to 2026.

Market Insights
Sepsis is fairly common across intensive care units (ICUs) in India, with the most prevalent organisms being gram-negative microbes. While ICU mortality rates in the country are high, especially in the case of severe sepsis, the care is resource-intensive, owing to the increased length of stay. In this regard, according to the recent study conducted by Nicholas Parry, in 2018, nearly 34% of sepsis patients in India die in ICUs. Statistics have also revealed the high estimations for patients with septic shock or severe sepsis, thereby placing the mortality rates at 40% to 60%. Besides, the elderly population experiences the highest incidence.
Therefore, sepsis continues to remain one of the most highly prevalent and life-threatening infections in India. Increased awareness across the population can significantly help minimize the death rates in the country, primarily through rapid diagnosis. As a result, these factors are predicted to facilitate the sepsis diagnostics market in India, over the forecast period.

Competitive Insights
Some of the prominent companies operating in the market are, Bruker Corporation, Thermo Fisher Scientific Inc, Abbott Laboratories, F. Hoffmann-La Roche, etc.
Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments